Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Shenzhen Hepalink Pharmaceutical Group Co Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), Shenzhen Hepalink Pharmaceutical Group Co Ltd tiene un total de activos de $17,343, una ganancia neta profit de $646

Question 2

¿Cuáles son los ratios financieros clave para SHEZF?

Accepted Answer

El ratio corriente de Shenzhen Hepalink Pharmaceutical Group Co Ltd es 3.33, el margen neto es 12.23, las ventas por acción son $3.59.

Question 3

¿Cómo se desglosan los ingresos de Shenzhen Hepalink Pharmaceutical Group Co Ltd por segmento o geografía?

Accepted Answer

Shenzhen Hepalink Pharmaceutical Group Co Ltd largest revenue segment is Preparation, at a revenue of 2,986,074,622 in the most earnings release.For geography, Europe is the primary market for Shenzhen Hepalink Pharmaceutical Group Co Ltd, at a revenue of 2,372,845,163.

Question 4

¿Es rentable Shenzhen Hepalink Pharmaceutical Group Co Ltd?

Accepted Answer

yes, según los últimos estados financieros, Shenzhen Hepalink Pharmaceutical Group Co Ltd tiene una ganancia neta profit de $646

Question 5

¿Tiene Shenzhen Hepalink Pharmaceutical Group Co Ltd alguna deuda?

Accepted Answer

yes, Shenzhen Hepalink Pharmaceutical Group Co Ltd tiene una deuda de 5,194

Question 6

¿Cuántas acciones en circulación tiene Shenzhen Hepalink Pharmaceutical Group Co Ltd?

Accepted Answer

Shenzhen Hepalink Pharmaceutical Group Co Ltd tiene un total de acciones en circulación de 1,467.29

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	5,260	5,280	5,445	7,159	6,365	5,332
Revenue Growth (YoY)	-6%	-3%	-24%	12%	19%	15%
Cost of Revenue	3,655	3,532	4,501	4,863	4,367	3,300
Gross Profit	1,605	1,748	944	2,295	1,998	2,031
Selling, General & Admin	855	781	930	972	878	767
Research & Development	233	203	173	244	216	154
Operating Expenses	1,297	1,099	1,232	1,292	1,186	996
Other Non Operating Income (Expenses)	0	-14	-66	1	-4	-1
Pretax Income	442	726	-928	829	222	1,327
Income Tax Expense	58	101	-126	114	-11	306
Net Income	404	646	-783	727	240	1,024
Net Income Growth	-267%	-183%	-208%	202.99%	-77%	-3%
Shares Outstanding (Diluted)	1,467.29	1,467.29	1,467.29	1,467.29	1,467.29	1,467.3
Shares Change (YoY)	0%	0%	0%	0%	0%	18%
EPS (Diluted)	0.27	0.44	-0.53	0.49	0.16	0.7
EPS Growth	-267%	-183%	-208%	202%	-77%	-18%
Free Cash Flow	1,751	1,991	-46	-979	-200	-175
Free Cash Flow Per Share	1.19	1.35	-0.03	-0.66	-0.13	-0.11
Gross Margin	30.51%	33.1%	17.33%	32.05%	31.39%	38.09%
Operating Margin	5.85%	12.27%	-5.28%	14.01%	12.74%	19.41%
Profit Margin	7.68%	12.23%	-14.38%	10.15%	3.77%	19.2%
Free Cash Flow Margin	33.28%	37.7%	-0.84%	-13.67%	-3.14%	-3.28%
EBITDA	--	744	-188	1,095	911	1,136
EBITDA Margin	--	14.09%	-3.45%	15.29%	14.31%	21.3%
D&A For EBITDA	--	96	100	92	100	101
EBIT	308	648	-288	1,003	811	1,035
EBIT Margin	5.85%	12.27%	-5.28%	14.01%	12.74%	19.41%
Effective Tax Rate	13.12%	13.91%	13.57%	13.75%	-4.95%	23.05%

Shenzhen Hepalink Pharmaceutical Group Co Ltd (SHEZF) Price

SHEZF Stock Price Chart

SHEZF Income

Follow-Up Questions